- •Preface
- •Contents
- •List of Abbreviations
- •Antibacterial Agents
- •A. TOPICAL ANTIBIOTICS
- •B. ORAL ANTIBIOTICS
- •C. ANTIBIOTICS FOR SUBCONJUNCTIVAL/INTRAVITREAL INJECTION
- •D. REGIMENS FOR SPECIFIC ORGANISMS
- •E. REGIMENS FOR SPECIFIC CLINICAL ENTITIES
- •7 Dacryocystitis
- •Antifungal Agents
- •A. AGENTS
- •B. SPECIFIC ANTI-FUNGAL REGIMENS
- •2 Molds
- •3 Dimorphic Fungi
- •Antiviral Agents
- •A. TOPICAL
- •B. SYSTEMIC
- •Anti-Parasitic Agents
- •A. PROTOZOA
- •B. HELMINTHS
- •Anti-Glaucoma Agents
- •D. HYPEROSMOLAR AGENTS
- •H. COMBINATION AGENTS
- •I. SPECIFIC REGIMENTS
- •2 Elevated Eye Pressure During Pregnancy
- •Neuro-Ophthalmology
- •A. AGENTS USED IN NEURO-OPHTHALMOLOGY
- •B. SPECIFIC REGIMENS
- •Anti-Inflammatory Agents
- •A. STEROIDAL
- •B. COMBINATION STEROID WITH ANTIBIOTIC
- •C. NONSTEROIDAL
- •D. MISCELLANEOUS
- •Mydriatics, Cycloplegics, and Reversal Agents
- •Lubricants and Viscoelastics
- •A. ARTIFICIAL TEARS, VISCOELASTICS, AND LUBRICATING OINTMENTS
- •Low Viscosity
- •High Viscosity
- •Unknown Viscosity
- •Insert
- •Gels & Ointments
- •Ointments
- •Gels
- •Viscoelastics
- •B. IRRIGATING SOLUTIONS
- •Miscellaneous
- •A. AGENTS FOR RELIEF OF SEASONAL ALLERGIC CONJUNCTIVITIS/OCULAR DISCOMFORT
- •B. OCULAR DECONGESTANTS
- •C. TOPICAL HYPEROSMOLAR AGENTS
- •D. VITAMINS
- •E. ANESTHETIC AGENTS
- •F. HOMEOPATHIC DRUGS
- •G. CAPSULE STAINING ADJUNCTS
- •H. MISCELLANEOUS
- •I. DRUGS FOR HYPHEMA
- •Anti-Angiogenesis Agents
- •Contact Lens Solutions
- •Contact Lens Solution Hypersensitivity
- •Soft Contact Lens Solutions
- •I. LISTING OF SOFT LENS PRODUCTS BY CATEGORY
- •A. Daily Cleaners
- •B. Enzymatic Cleaners
- •C. Daily Protein Removers
- •D. Rewetting/Lubricating Drops
- •E. Oxidation Solutions/Systems
- •F. Saline Solutions
- •G. Combination Solutions
- •II. SOFT LENS PRODUCTS LISTED BY SYSTEM AND MANUFACTURER: NOT ALL PRODUCTS ARE LISTED IN THIS SECTION BECAUSE NOT ALL PRODUCTS BELONG TO A PARTICULAR SYSTEM
- •Rigid Lens Solutions
- •I. LISTING OF RIGID LENS RODUCTS BY CATEGORY
- •A. Daily Cleaners
- •C. Daily Protein Remover
- •D. Oxidation Systems
- •E. Storage and Disinfection
- •F. Wetting/Rewetting
- •G. Combination Solutions
- •APPENDIX 1: TOPICAL ANTIBACTERIAL SPECTRUM
- •APPENDIX 2: A PREPARING FORTIFIED TOPICAL ANTIBIOTICS AND PREPARING ORAL ACETAZOLAMIDE SOLUTION
- •Fortified Bacitracin
- •Fortified Cefazolin
- •Fortified Vancomycin
- •APPENDIX 3: ANTI-FUNGAL ACTIVITY SPECTRUM
- •APPENDIX 4: RENAL DOSING FOR SELECTED DRUGS
- •Cidofovir Dosing in Renal Failure*
- •Famciclovir Dosing in Renal Failure*
- •Foscarnet Dosing in Renal Failure*
- •Intravenous Ganciclovir Dosing in Renal Failure*
- •Oral Ganciclovir Dosing in Renal Failure*
- •Valacyclovir Dosing in Renal Failure*
- •APPENDIX 5: GLAUCOMA MEDICATION PRESERVATIVES
- •APPENDIX 6: TITRATING TOPICAL DROPS FOR CHILDREN
- •Product Index
- •Subject Index
94
E. ANESTHETIC AGENTS
(1) Topical Anestheticsc
Drug |
Trade |
Preparation |
Dose |
Notes |
benoxinate |
Fluress, Fluorox |
Soln, 0.4% with 0.25% |
1 drop |
Duration 15–30 min, Ester |
|
|
fluorescein sodium |
|
linkage, preserved with |
|
|
|
|
chlorobutanol |
cocaine |
N/A |
Soln, 1%–4% |
1 drop |
Duration 20–45 min, pupillary |
hydrochloride |
|
|
|
dilation, potentiates |
|
|
|
|
epinephrine |
paracaine |
OCuSOFT |
Soln, 0.5% |
1 drop |
|
proparacaine |
AK-Taine, Alcaine, Ocu-Caine, |
Soln, 0.5% |
1 drop |
Duration 15–30 min. |
|
Ophthaine, Ophthetic |
|
|
Ester linkage, Ophthetic |
|
|
|
|
preserved with benzalkonium |
|
|
|
|
chloride |
|
Fluorocaine |
Soln, 0.5% with 0.25% |
1 drop |
|
|
|
fluorescein sodium |
|
|
tetracaine |
AK-T-Caine, Pontocaine |
Soln, 0.5% |
1 drop |
Duration 9–24 min. |
|
|
|
|
Ester linkage |
|
|
|
|
|
Notes: 1) Topical anesthetics should only be used to allow the clinician to perform ocular procedures. They are not indicated for use by the patient and should never be prescribed.
2)Allergies to topical anesthetic drops may be a reaction to the medication itself, class of linkage (e.g. amide versus ester), or simply the preservative.
(2) Local Anestheticsc (To convert percent solutions to mg/ml, multiply by 10; e.g. 1% = 10 mg/ml)
Drug |
Trade |
Preparation |
Maximum Adult Dose |
Duration of Action |
Pain on Injectionx |
Linkage1 |
|
bupivacaine |
Marcaine, |
Soln, 0.25–0.75% |
23 ml of 0.75% soln |
3 to 12 hrs |
|
5 |
Amide |
|
Sensorcaine |
|
|
|
|
|
|
chloroprocaine |
Nesacaine |
Soln, 1–3% |
40 ml of 2% soln |
60 min |
|
N/A |
Ester |
etidocaine |
Duranest |
Soln 1% |
40 ml of 1% soln |
5–10 hrs |
|
N/A |
Amide |
hexylcaine |
|
Soln, 1–2% |
|
60 min |
|
N/A |
Ester |
lidocaine |
Xylocaine |
|
|
|
|
|
Amide |
Without epinephrine |
Soln, 1–2% |
15 ml of 2% soln |
60 to 75 min. |
1 |
|
||
With epinephrine |
Soln, 1–2% |
25 ml of 2% soln |
2 hrs. |
2 |
|
||
mepivacaine |
Carbocaine |
Soln, 1–2% |
15 ml of 2% soln |
2 to 3 hrs |
4 |
Amide |
|
procaine |
Novocaine |
Soln, 1–4% |
38 ml of 2% soln |
30 to 45 min. |
3 |
Ester |
|
|
|
|
|
|
|
|
|
(3) Adjunctsc
Drug |
Trade |
Preparation |
Usual Dose |
Notes |
hyaluronidase |
Vitrase |
200 USP units/ml |
50–300 units, typical dose 150 |
Depolymerizes polysaccharides and increases |
|
|
|
USP units |
effective area of anesthesia, decreases |
|
|
|
|
duration of local anesthesia |
|
|
Lyophilized, 6200 Reconstitute to 1000 USP |
Depolymerizes polysaccharides and increases |
|
|
|
USP units |
units/vial by adding 6.2 ml of |
effective area of anesthesia, decreases |
|
|
|
solution to the vial. Common |
duration of local anesthesia |
|
|
|
dose is 150 USP units |
|
sodium bicarbonate |
|
1 mEq/ml |
1 ml in 10 ml anesthetic |
Decreases pain on injection |
|
|
|
|
|
Miscellaneous 95
